DK137189B - Fremgangsmåde til fremstilling af quinolinderivater. - Google Patents

Fremgangsmåde til fremstilling af quinolinderivater.

Info

Publication number
DK137189B
DK137189B DK126671AA DK126671A DK137189B DK 137189 B DK137189 B DK 137189B DK 126671A A DK126671A A DK 126671AA DK 126671 A DK126671 A DK 126671A DK 137189 B DK137189 B DK 137189B
Authority
DK
Denmark
Prior art keywords
preparation
quinoline derivatives
quinoline
derivatives
Prior art date
Application number
DK126671AA
Other languages
Danish (da)
English (en)
Other versions
DK137189C (fr
Inventor
Guenter Grethe
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to DK44773A priority Critical patent/DK136983B/da
Priority to DK232876A priority patent/DK232876A/da
Publication of DK137189B publication Critical patent/DK137189B/da
Application granted granted Critical
Publication of DK137189C publication Critical patent/DK137189C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK126671AA 1970-03-16 1971-03-16 Fremgangsmåde til fremstilling af quinolinderivater. DK137189B (da)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DK44773A DK136983B (da) 1970-03-16 1973-01-26 Fremgangsmåde til fremstilling af quinolinderivater.
DK232876A DK232876A (da) 1970-03-16 1976-05-26 Fremgangsmade til fremstilling af quinolinderivater

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2003470A 1970-03-16 1970-03-16

Publications (2)

Publication Number Publication Date
DK137189B true DK137189B (da) 1978-01-30
DK137189C DK137189C (fr) 1978-07-03

Family

ID=21796376

Family Applications (1)

Application Number Title Priority Date Filing Date
DK126671AA DK137189B (da) 1970-03-16 1971-03-16 Fremgangsmåde til fremstilling af quinolinderivater.

Country Status (14)

Country Link
AT (1) AT341116B (fr)
BE (1) BE764252A (fr)
CA (1) CA940530A (fr)
CH (2) CH590275A5 (fr)
DE (1) DE2111938A1 (fr)
DK (1) DK137189B (fr)
FR (1) FR2100618B1 (fr)
GB (1) GB1313963A (fr)
IE (1) IE35284B1 (fr)
IL (1) IL36400A (fr)
NL (1) NL7103506A (fr)
PH (1) PH9976A (fr)
SE (1) SE395699B (fr)
ZA (1) ZA711588B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH605916A5 (fr) * 1973-12-07 1978-10-13 Hoffmann La Roche
FR2381044A1 (fr) * 1977-02-17 1978-09-15 Hoffmann La Roche Procede pour la preparation de mefloquine
EP0000302B1 (fr) * 1977-06-15 1980-10-01 Devinter S.A. Nouveau procédé de préparation de la quinidine.
EP1212322A2 (fr) 1999-08-27 2002-06-12 Ligand Pharmaceuticals Incorporated Composes de 6-trifluoromethyl-9-pyrido[3,2-g]quinoline 8-substitues utilises comme modulateurs de recepteurs androgenes
WO2001016139A1 (fr) * 1999-08-27 2001-03-08 Ligand Pharmaceuticals Incorporated Composes de modulation du recepteur androgene et procedes d'utilisation
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
AU7586600A (en) 1999-09-14 2001-04-17 Ligand Pharmaceuticals Incorporated Rxr modulators with improved pharmacologic profile

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH533123A (de) * 1968-07-02 1973-01-31 Hoffmann La Roche Verfahren zur Herstellung von Chinolinderivaten

Also Published As

Publication number Publication date
ZA711588B (en) 1971-12-29
FR2100618B1 (fr) 1974-08-23
IL36400A0 (en) 1971-05-26
DE2111938A1 (de) 1971-10-07
CH590275A5 (fr) 1977-07-29
IE35284L (en) 1971-09-16
CH590274A5 (fr) 1977-07-29
DK137189C (fr) 1978-07-03
IE35284B1 (en) 1976-01-07
PH9976A (en) 1976-06-16
BE764252A (fr) 1971-09-15
SE395699B (sv) 1977-08-22
CA940530A (en) 1974-01-22
AT341116B (de) 1978-01-25
IL36400A (en) 1973-07-30
GB1313963A (en) 1973-04-18
ATA220971A (de) 1977-05-15
NL7103506A (fr) 1971-09-20
FR2100618A1 (fr) 1972-03-24

Similar Documents

Publication Publication Date Title
DK127927B (da) Analogifremgangsmåde til fremstilling af kinolinderivater.
DK136215B (da) Analogifremgangsmåde til fremstilling af kinolinderivater.
DK129339B (da) Analogifremgangsmåde til fremstilling af N-aminophenylamidiner.
DK137955B (da) Analogifremgangsmåde til fremstilling af morphinan-derivater.
DK135455B (da) Fremgangsmåde til fremstilling af 7-halogen-7-desoxythiolincosaminider.
DK125089B (da) Analogifremgangsmåde til fremstilling af evomonosidderivater.
DK126944B (da) Analogifremgangsmåde til fremstilling af hexahydrobenzindolderivater.
DK137189B (da) Fremgangsmåde til fremstilling af quinolinderivater.
DK134489B (da) Fremgangsmåde til fremstilling af alkyl-7-desoxy-7(S)-substituerede-alfa-thiolincosaminider.
DK128778B (da) Analogifremgangsmåde til fremstilling af bis-2-carboxy-chromonylderivater.
DK128496B (da) Fremgangsmåde til fremstilling af 5-fluoruracilderivater.
DK136361B (da) Fremgangsmåde til fremstilling af quinolin-derivater.
DK130467B (da) Fremgangsmåde til fremstilling af erythromycylaminer.
DK128895B (da) Fremgangsmåde til fremstilling af pregnanderivater.
DK136982B (da) Fremgangsmåde til fremstilling af quinolinderivater.
DK138490B (da) Fremgangsmåde til fremstilling af prostadiensyrederivater.
DK134154B (da) Analogifremgangsmåde til fremstilling af 5-cyklohexyl-1-indankarboxylsyrederivater.
DK127977B (da) Fremgangsmåde til fremstilling af 6α-methyl-19-nor-pregnener.
DK137181B (da) Analogifremgangsmåde til fremstilling af 3-amino-kinolinderivater.
DK128205B (da) Fremgangsmåde til fremstilling af 1-aryloxy-2-propanoler.
DK129453B (da) Analogifremgangsmåde til fremstilling af 1-aminoisoquinoliner.
DK126323B (da) Fremgangsmåde til fremstilling af 3β-hydroxy-5α-cardenolider eller -bufadienolider.
DK123096B (da) Analogifremgangsmåde til fremstilling af neriifolinderivater.
DK125388B (da) Fremgangsmåde til fremstilling af phenylaminoethanolderivater.
DK137860B (da) Analogifremgangsmåde til fremstilling af triazolobenzodiazepin-5N-oxydderivater.